Impact of mediastinal, liver and lung 123I- metaiodobenzylguanidine (123I-MIBG) washout on calculated 123I-MIBG myocardial washout

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 8, 2009, Pages 1322-1328

  Verberne, Hein J ^a   Somsen, G Aernout ^b   Povinec, Pavol ^c   Van Eck Smit, Berthe L F ^a   Jacobson, Arnold F ^d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^c BIONT   (Slovakia)

^d GE HEALTHCARE   (United States)

Author keywords

Heart failure; MIBG; Quantification

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART SCINTISCANNING; HUMAN; HYPERTENSION; IMAGE ANALYSIS; LIVER; LUNG; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM; PREDICTION; ARTIFACT; HEART; HEART MUSCLE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; SCINTISCANNING; TIME;

3-IODOBENZYLGUANIDINE; ADULT; ARTIFACTS; FEMALE; HEART; HEART FAILURE; HUMANS; HYPERTENSION; LIVER; LUNG; MALE; MEDIASTINUM; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIUM; TIME FACTORS;

EID: 70349254284     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-009-1093-1     Document Type: Article

References (34)

1. JC Sisson B Shapiro L Meyers S Mallette TJ Mangner DM Wieland, et al. 1987 Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man J Nucl Med 28 1625 1636 3655915 1:CAS:528:DyaL1MXmvFCrtA%3D%3D
2. RC Kline DP Swanson DM Wieland JH Thrall MD Gross B Pitt, et al. 1981 Myocardial imaging in man with I-123 meta-iodobenzylguanidine J Nucl Med 22 129 132 7463156 1:CAS:528:DyaL3MXhtFKru78%3D
3. P Merlet H Valette JL Dubois-Randé D Moyse D Duboc P Dove, et al. 1992 Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure J Nucl Med 33 471 477 1552326 1:STN:280:DyaK383gt12rtA%3D%3D
4. P Merlet C Benvenuti D Moyse F Pouillart JL Dubois-Randé AM Duval, et al. 1999 Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy J Nucl Med 40 917 923 10452306 1:STN:280:DyaK1MznvFektw%3D%3D
5. M Momose H Kobayashi N Iguchi N Matsuda Y Sakomura H Kasanuki, et al. 1999 Comparison of parameters of 123I-MIBG scintigraphy for predicting prognosis in patients with dilated cardiomyopathy Nucl Med Commun 20 529 535 10451865 10.1097/00006231-199906000-00007 1:STN:280:DyaK1MzotFWksA%3D%3D
6. A Cohen-Solal Y Esanu D Logeart F Pessione C Dubois G Dreyfus, et al. 1999 Cardiac metaiodobenzylguanidine uptake in patients with moderate chronic heart failure: relationship with peak oxygen uptake and prognosis J Am Coll Cardiol 33 759 766 10080478 10.1016/S0735-1097(98)00608-1 1:STN:280: DyaK1M7nvVGlsQ%3D%3D
7. T Wakabayashi T Nakata A Hashimoto S Yuda K Tsuchihashi MI Travin, et al. 2001 Assessment of underlying etiology and cardiac sympathetic innervation to identify patients at high risk of cardiac death J Nucl Med 42 1757 1767 11752070 1:STN:280:DC%2BD38%2FgtlOhtg%3D%3D
8. S Kasama T Toyama H Kumakura Y Takayama S Ichikawa T Suzuki, et al. 2002 Spironolactone improves cardiac sympathetic nerve activity and symptoms in patients with congestive heart failure J Nucl Med 43 1279 1285 12368364 1:CAS:528:DC%2BD38XotlKjs78%3D
9. T Yamada T Shimonagata M Fukunami K Kumagai H Ogita A Hirata, et al. 2003 Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: a prospective study J Am Coll Cardiol 41 231 238 12535815 10.1016/S0735-1097(02)02700-6 (Pubitemid 36092191)
10. M Kyuma T Nakata A Hashimoto K Nagao H Sasao T Takahashi, et al. 2004 Incremental prognostic implications of brain natriuretic peptide, cardiac sympathetic nerve innervation, and noncardiac disorders in patients with heart failure J Nucl Med 45 155 163 14960630 1:CAS:528:DC%2BD2cXitVCrtLk%3D
11. T Nakata T Wakabayashi M Kyuma T Takahashi K Tsuchihashi K Shimamoto 2005 Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure Eur J Nucl Med Mol Imaging 32 186 194 15452671 10.1007/s00259-004-1624-8 1:CAS:528:DC%2BD2MXpsFyrsw%3D%3D (Pubitemid 40248490)
12. S Kasama T Toyama H Sumino M Nakazawa N Matsumoto Y Sato, et al. 2008 Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction J Nucl Med 49 907 914 18483106 10.2967/jnumed.107.047548 (Pubitemid 351793431)
13. HJ Verberne LM Brewster GA Somsen BL van Eck-Smit 2008 Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review Eur Heart J 29 1147 1159 18349024 10.1093/eurheartj/ehn113 (Pubitemid 351844881)
14. R Arora KJ Ferrick T Nakata RC Kaplan M Rozengarten F Latif, et al. 2003 I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator J Nucl Cardiol 10 121 131 12673176 10.1067/mnc.2003.2 (Pubitemid 36503797)
15. M Paul M Schäfers P Kies T Acil K Schäfers G Breithardt, et al. 2006 Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation Eur J Nucl Med Mol Imaging 33 866 870 16612587 10.1007/s00259-005- 0061-7 (Pubitemid 44127434)
16. H Kioka T Yamada T Mine T Morita Y Tsukamoto S Tamaki, et al. 2007 Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging Heart 93 1213 1218 17344327 10.1136/hrt.2006.094524 (Pubitemid 47492905)
17. MA Rabinovitch CP Rose AJ Schwab DH Fitchett GN Honos JA Stewart, et al. 1993 A method of dynamic analysis of iodine-123-metaiodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure J Nucl Med 34 589 600 8455075 1:STN:280:DyaK3s3gtl2gtw%3D%3D
18. AS Arbab K Koizumi K Toyama T Arai T Araki 1999 Dynamic SPET parameters of 123I-MIBG cardiac imaging Nucl Med Commun 20 617 622 10423763 10.1097/00006231-199907000-00004 1:STN:280:DyaK1Mzlt1GlsA%3D%3D
19. EB Henderson JK Kahn JR Corbett DE Jansen JJ Pippin P Kulkarni, et al. 1988 Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy Circulation 78 1192 1199 3180378 1:STN:280:DyaL1M%2FivFSgsQ%3D%3D
20. K Nakajima J Taki N Tonami K Hisada 1994 Decreased 123I-MIBG uptake and increased clearance in various cardiac diseases Nucl Med Commun 15 317 323 8047317 10.1097/00006231-199405000-00003 1:STN:280:DyaK2czitlWgsQ%3D%3D
21. C Kurata Y Wakabayashi S Shouda K Okayama T Yamamoto A Ishikawa, et al. 1995 Enhanced cardiac clearance of iodine-123-MIBG in chronic renal failure J Nucl Med 36 2037 2043 7472594 1:STN:280:DyaK28%2FkvFWjsA%3D%3D
22. JV Glowniak FE Turner LL Gray RT Palac MC Lagunas-Solar WR Woodward 1989 Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants J Nucl Med 30 1182 1191 2661758 1:STN:280:DyaL1M3ptlensw%3D%3D
23. J Taki K Nakajima H Bunko M Simizu A Muramori K Hisada 1990 Whole-body distribution of iodine 123 metaiodobenzylguanidine in hypertrophic cardiomyopathy: significance of its washout from the heart Eur J Nucl Med 17 264 268 2128050 10.1007/BF00812368 1:STN:280:DyaK3M7pt1Skuw%3D%3D
24. I Carrió 2001 Cardiac neurotransmission imaging J Nucl Med 42 7 1062 1076 11438630
25. S Yamashina J Yamazaki 2007 Neuronal imaging using SPECT Eur J Nucl Med Mol Imaging 34 Suppl 1 S62 S73 17450357 10.1007/s00259-007-0441-2 1:CAS:528:DC%2BD2sXosVaqt7o%3D (Pubitemid 46956022)
26. Agostini D, Carrio I, Verberne HJ. How to use myocardial (123)I-MIBG scintigraphy in chronic heart failure. Eur J Nucl Med Mol Imaging. 2008; In press.
27. GA Somsen JJ Borm EA Dubois MB Schook EE Van der Wall EA Van Royen 1996 Cardiac 123I-MIBG uptake is affected by variable uptake in reference regions: implications for interpretation in clinical studies Nucl Med Commun 17 872 876 8951908 10.1097/00006231-199610000-00008 1:STN:280:DyaK2s7gvFKhug%3D%3D
28. D Agostini HJ Verberne W Burchert J Knuuti P Povinec G Sambuceti, et al. 2008 I-123-mIBG myocardial imaging for assessment of risk for a major cardiac event in heart failure patients: insights from a retrospective European multicenter study Eur J Nucl Med Mol Imaging 35 535 546 18043919 10.1007/s00259-007-0639-3
29. DD Watson NP Campbell EK Read RS Gibson CD Teates GA Beller 1981 Spatial and temporal quantitation of plane thallium myocardial images J Nucl Med 22 577 584 7252561 1:CAS:528:DyaL3MXksFOhtb4%3D
30. Y Imamura T Fukuyama 2002 Prognostic value of myocardial MIBG scintigraphy findings in patients with cardiomyopathy-importance of background correction for quantification of MIBG activity Ann Nucl Med 16 387 393 12416577 10.1007/BF02990076
31. M Suwa Y Otake A Moriguchi T Ito Y Hirota K Kawamura, et al. 1997 Iodine-123 metaiodobenzylguanidine myocardial scintigraphy for prediction of response to beta-blocker therapy in patients with dilated cardiomyopathy Am Heart J 133 353 358 9060806 10.1016/S0002-8703(97)70232-1 1:CAS:528: DyaK2sXitFarurg%3D
32. FI Parthenakis VK Prassopoulos SI Koukouraki EA Zacharis GF Diakakis NK Karkavitsas, et al. 2002 Segmental pattern of myocardial sympathetic denervation in idiopathic dilated cardiomyopathy: relationship to regional wall motion and myocardial perfusion abnormalities J Nucl Cardiol 9 15 22 11845125 10.1067/mnc.2002.118239 1:STN:280:DC%2BD387kvVShsw%3D%3D (Pubitemid 34196226)
33. HJ Verberne C Feenstra WM de Jong GA Somsen BL van Eck-Smit E Busemann Sokole 2005 Influence of collimator choice and simulated clinical conditions on 123I-MIBG heart/mediastinum ratios: a phantom study Eur J Nucl Med Mol Imaging 32 1100 1107 15902438 10.1007/s00259-005-1810-3 (Pubitemid 41339287)
34. J Chen EV Garcia JR Galt RD Folks I Carrio 2006 Improved quantification in 123I cardiac SPECT imaging with deconvolution of septal penetration Nucl Med Commun 27 551 558 16794515 10.1097/00006231-200607000-00002 (Pubitemid 44305310)